FDA approves Boehringer's olodaterol

FDA approved Striverdi Respimat olodaterol from Boehringer Ingelheim GmbH (Ingelheim, Germany) to treat airflow limitations in patients with chronic obstructive pulmonary disease (COPD). Boehringer sa...